Get started
Author

Shoulai Gu

Overexpression of BnWRKY33 in oilseed rape enhances resistance to S clerotinia sclerotiorum
2014 · Zheng Wang, Hedi Fang, et al. · Molecular Plant Pathology · 117
PDF
Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment
2017 · Jingjing Xie, Xiaojia Si, et al. · Journal of Medicinal Chemistry · 108
Defense to Sclerotinia sclerotiorum in oilseed rape is associated with the sequential activations of salicylic acid signaling and jasmonic acid signaling
2011 · Zheng Wang, Xiaoli Tan, et al. · Plant Science · 98
Long Chain Acyl-Coenzyme A Synthetase 4 (BnLACS4) Gene from Brassica napus Enhances the Yeast Lipid Contents
2014 · Xiao-li TAN, Xiang-feng ZHENG, et al. · Journal of Integrative Agriculture · 28
PDF
A Peroxisomal Long-Chain Acyl-CoA Synthetase from Glycine max Involved in Lipid Degradation
2014 · Lili Yu, Xiaoli Tan, et al. · PLoS ONE · 27
PDF
Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3- c ]pyridine derivatives as potent and selective CYP17 inhibitors
2017 · Mingliang Wang, Yanjia Fang, et al. · European Journal of Medicinal Chemistry · 12
AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent
2024 · Qiuqiong Tang, Deyong Xiao, et al. · Aging and Disease · 10
PDF
Abstract 2058: BCL-2 selective inhibitor APG-2575 synergizes with BTK inhibitor in preclinical xenograft models of follicular lymphoma and diffuse large B-cell lymphoma
2019 · Douglas D. Fang, Guoqin Zhai, et al. · Cancer Research · 3
Abstract 73: Development of APG-3526 as a novel and highly efficacious MCL-1 inhibitor
2020 · Jianyong Chen, Chengzhe Wu, et al. · Cancer Research · 2
Abstract 3939: Preclinical development of embryonic ectoderm development (EED) inhibitor APG-5918/EEDi-5273 for cancer therapy
2022 · Saijie Zhu, Douglas D. Fang, et al. · Cancer Research · 1
Abstract 6216: Therapeutic potential of IAP inhibitor APG-1387 in combination with PARP- or MEK-targeted therapy, or chemotherapy in pancreatic cancer
2020 · Qiang Li, Douglas D. Fang, et al. · Cancer Research
Abstract 2204: Novel FAK/ALK/ROS1 inhibitor APG-2449 synergizes with osimertinib in preclinical xenograft models of EGFR-mutant NSCLC
2019 · Guangfeng Wang, Douglas D. Fang, et al. · Cancer Research
Abstract 3068: Synergistic effect of BCL-2 inhibitor APG-2575 and CDK9 inhibitor in acute myeloid leukemia and DLBCL preclinical tumor models
2019 · Douglas D. Fang, Ran Tao, et al. · Cancer Research
Abstract 3068: Synergistic effect of BCL-2 inhibitor APG-2575 and CDK9 inhibitor in acute myeloid leukemia and DLBCL preclinical tumor models
2019 · Douglas D. Fang, Ran Tao, et al. · Experimental and Molecular Therapeutics
Abstract 2204: Novel FAK/ALK/ROS1 inhibitor APG-2449 synergizes with osimertinib in preclinical xenograft models of EGFR-mutant NSCLC
2019 · Guangfeng Wang, Douglas D. Fang, et al. · Experimental and Molecular Therapeutics
Abstract 2058: BCL-2 selective inhibitor APG-2575 synergizes with BTK inhibitor in preclinical xenograft models of follicular lymphoma and diffuse large B-cell lymphoma
2019 · Douglas D. Fang, Guoqin Zhai, et al. · Experimental and Molecular Therapeutics
Works count: 16
Citation count: 406
H-index: 7
I10-index: 7
Year
Topic
Type